Overcoming Cost and Infrastructure Barriers in Advanced Therapy Trials
The cell and gene therapy clinical trials market is on the brink of unprecedented expansion, poised to grow from USD 9.48 billion in 2023 to USD 32.96 billion by 2032, reflecting a robust CAGR of 14.87% during the forecast period 2024–2032. This remarkable growth trajectory underscores the transformative potential of cell and gene therapies in revolutionizing healthcare and...
0 Comments 0 Shares 14 Views 0 Reviews
Sponsored